Market News
Obalon Therapeutics (NASDAQ: OBLN): Q3 2019 Earnings Snapshot
— Obalon Therapeutics (NASDAQ: OBLN) reported a net loss of $0.61 per share for the third quarter of 2019, vs. $2.14 per share loss expected.…